SKALP/elafin gene polymorphisms are not associated with pustular forms of psoriasis

Clinical Genetics

Volumn 54, Issue 1, 1998, Pages 96-101

  Kuijpers, Astrid L A ^a   Pfundt, Rolph ^a   Zeeuwen, Patrick L J M ^a   Molhuizen, Henri O F ^a   Mariman, Edwin C M ^a   Van De Kerkhof, Peter C M ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Polymorphonuclear leukocyte; Protease inhibitor; Proteinase; Psoriasis; Pustule formation

Indexed keywords

DNA; ELAFIN; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; ENZYME ACTIVITY; EXON; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PSORIASIS; PUSTULE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0031927384     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb03703.x     Document Type: Article

References (29)

1. Baadsgaard O, Tong P, Elder JT, Hansen ER, Ho V, Hammerberg C, Lange Vejlsgaard G, Fox DA, Fisher G, Chan LS et al. UM4D4 + (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. J Invest Dermatol 1990: 95: 275-282.
2. Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ Jr, Ellingsworth L, Derynck R, Voorhees JJ. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 1989: 243: 811-814.
3. Lomholt G. Psoriasis, Prevalence, Spontaneous Course and Genetics. Copenhagen: GEC, GAD, 1963.
4. Farber EM, Nail ML, Watson W. Natural history of psoriasis in 61 twin pairs. Arch Dermatol 1974: 109: 207-211.
5. Matthews D, Fry L, Powles A, Weber J, McCarthy M, Fisther E, Davies K, Williamson R. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nat Genet 1996: 14: 231-233.
6. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RDR, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM, Barker JNWN. Identification of a major susceptibility locus on chromosome 6P and evidence for further disease loci revealed by a two stage genome wide search in psoriasis. Hum Mol Genet 1997: 6: 813-820.
7. Nair RP, Guo SW, Jenisch S, Henseler T, Lange EM, Terhune M, Westphal E, Christophers E, Voorhees JJ, Elder JT. Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered 1995: 45: 219-230.
8. Tomfohrde J, Silverman A, Barnes R, Fernandez Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994: 264: 1141-1145.
9. Ward JM, Barnes RM. HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasis. Br J Dermatol 1978: 99: 477-483.
10. Torii H, Nakagawa H, Ishibashi Y, Tokunaga K, Juji T. Genetic polymorphisms in HLA-A, -B, -C and -DR antigens in Japanese patients with palmoplantar pustulosis. Dermatology 1994: 188: 290-292.
11. Ternowitz T. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis. J Am Acad Dermatol 1986: 15: 1191-1199.
12. Takematsu H, Terui T, Ohkohchi K, Tagami H, Suzuki R, Kumagai K. Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses. Acta Derm Venereol Stockh 1986: 66: 93-97.
13. Lundin A, Hakansson L, Michaelsson G, Venge P. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis. Arch Dermatol Res 1987: 279: 385-391.
14. Schalkwijk J, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP) an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim Biophys Acta 1991: 1096: 148-154.
15. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 1990: 265: 14791-14795.
16. Zeeuwen PLJM, Hendriks W, de Jong WW, Schalkwijk J. Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature. J Biol Chem 1997: 272: 20471-20478.
17. Chang A, Schalkwijk J, Happle R, van de Kerkhof PC. Elastase-inhibiting activity in scaling skin disorders. Acta Derm Venereol 1990: 70: 147-151.
18. Pfundt R, van Ruissen F, van Vlijmen-Willems IMJJ, Alkemade HAC, Zeeuwen PLJM, Jap PH, Dijkman JA, Fransen J, Croes H, van Erp PEJ, Schalkwijk J. Constitutive and inducible expression of SKALP elafin provides anti-elastase defense in human epithelia. J Clin Invest 1996: 98: 1389-1399.
19. Kuijpers ALA, Zeeuwen PLJM, de Jongh G, van de Kerkhof PCM, Alkemade HAC, Schalkwijk J. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation? Arch Dermatol Res 1996: 288: 641-647.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
21. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993: 16: 325-332.
22. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989: 86: 2766-2770.
23. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977: 74: 5463-5467.
24. Molhuizen HOF, Schalkwijk J. Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol Chem Hoppe-Seyler 1995: 376: 1-7.
25. Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J. SKALP elafin: an elastase inhibitor from cultured human keratinocytes. Purification. cDNA sequence, and evidence for transglutaminase cross-linking. J Biol Chem 1993: 268: 12028-12032.
26. Sallenave JM, Silva A. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am J Respir Cell Mol Biol 1993: 8: 439-445.
27. Saheki T, Ito F, Hagiwara H, Saito Y, Kuroki J, Tachibana S, Hirose S. Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem Biophys Res Commun 1992: 185: 240-245.
28. Kuijpers ALA, Schalkwijk J, Rulo HFC, Peperkamp J, van de Kerkhof PCM, de Jong EMGJ. Extremely low levels of epidermal skin-derived antileukoproteinase/elafin in a patient with impetigo herpetiformis. Br J Dermatol 1997: 137: 123-129.
29. Zhang M, Zou Z, Maass N, Sager R. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res 1995: 55: 2537-2541.